Skip To Main Content
Yin Chao Wu on Muck Rack

Yin Chao Wu

As seen in: Nature, Wiley Online Library, MDPI, ACS Publications, JAMA Network, Royal Society of Chemistry, Journal of Sensors, Canadian Journal of Infectious Diseases & Medical Microbiology, Dove Medical Press, King's College London and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yin Chao

Contact Yin Chao, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Mental Health Symptom Changes by Sex or Gender Before and During the COVID-19 Pandemic : A Systematic Review and Meta-Analysis

|
By Yin Chao Wu, Suiqiong Fan, Nadia González-Domínguez, Ying Sun, Letong Li, Kexin Li, Xiaowen Jiang, Amina Tasleem, Yutong Wang, Jill T. Boruff, Palak Desai, Ankur Krishnan, Claire Adams, Chen He, Richard Henry, Afra Alkan, Danielle Rice, Sarah Markham, Marleine Azar, Elsa-Lynn Nassar, Sophie Hu, Mara Cañedo-Ayala, Dipika Neupane, Andrea Benedetti, Brett D. Thombs, Brienne Tougas, Monica D’Onofrio
| JAMA Network Verified
Mental Health Symptom Changes by Sex or Gender Before and During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis Supplement 1. eMethods 1. Search Strategy eMethods 2. Title and Abstract and Full-Text Review Inclusion and Exclusion Criteria Coding Guides eMethods 3. Adequacy of Study Methods and Reporting—Adapted Joanna Briggs Institute Checklist for Prevalence Studies eTable 1.
Open in Who Shared Issue with article?

Venetoclax, azacitidine, and G-CSF targeting molecular residual disease in CBFB::MYH11 AML resistant to high-dose cytarabine

|
By Ting Shi, Ruicong Xue, Jing Jia, Menghan Liu, Yalan Zhou, Chuanying Geng, Yuan Jian, Ying Tian Verified, Yanru Zhang, Wenjing Li, Lefu Huang, Huixing Zhou, Aijun Liu, Wen Gao, Wenming Chen, Yin Chao Wu, Hong-Hu Zhu, Yun Leng
| Nature Verified
Dear Editor, Acute myeloid leukemia (AML) with the CBFB::MYH11 rearrangement is generally considered a favorable-risk subtype highly responsive to intensive cytarabine-based chemotherapy [1]. However, up to 30% of patients ultimately relapse, driven largely by persistent measurable residual disease (MRD) [1].
Open in Who Shared Issue with article?

Harnessing the potential of γδ T cells through engineering and combination treatment for cancer therapies

|
By Jonathan Fisher, Yin Chao Wu, Daniel Abate-Daga, Marta Barisa, Lawrence Lamb
| Nature Verified
Abstract γδT cells comprise 1-10% of circulating T cells, are further enriched in barrier tissues such as the gut and skin, and also form a critical component of lymphoid stress surveillance. γδ T cells have been gaining prominence as an alternative to αβ T cells for cancer immunotherapy. Such popularity may be attributed to multiple factors including the MHC-independent nature of γδ T activation, which differentiates them from αβ T cells and underlies their lack of alloreactivity.
Open in Who Shared Issue with article?
See all 37 licensed articles (40 Total)